Haisco Pharmaceutical (001367.SZ) disclosed the 2024 Restricted Stock Incentive Plan (draft), proposing to grant 2.3 million restricted stocks to incentive recipients (including an initial grant of 2.043 million restricted stocks and reserving 0.257 million restricted stocks), at a grant price of 12.65 yuan per share. A total of 87 recipients are planned to receive the initial grant of incentives.
In addition, the term of this incentive plan is from the date of the initial registration of the restricted stock until the expiration of the maximum period of 60 months after all the restricted stocks granted to the incentive recipients are released from the restrictions or repurchased and cancelled.
Intelligent Financial News APP, Haisco Pharmaceutical (001367.SZ) disclosed the 2024 Restricted Stock Incentive Plan (draft), proposing to grant 2.3 million restricted stocks to incentive recipients (including an initial grant of 2.043 million restricted stocks and reserving 0.257 million restricted stocks), at a grant price of 12.65 yuan per share. A total of 87 recipients are planned to receive the initial grant of incentives.